Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT07089758
The purpose of this study is to evaluate the safety and feasibility of intra-operative microperfusion during a planned neurosurgical resection of diseased brain parenchyma, including either an epileptic focus requiring temporal lobectomy or a glioma. Devices used for microperfusion are Joanneum Research cerebral open flow microperfusion (OFM) catheters, push and pull tubing, and MPP102-II pump.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will undergo intra-operative microperfusion using Joanneum Research's cerebral open flow microperfusion (OFM) catheters, push and pull tubing, and MPP102-II pump. This process utilizes a probe (catheter) inserted into the parenchyma to collect analytes of any size and polarity from the microenvironment. The microperfusion pump peristaltically pushes and pulls perfusate with no net fluid-exchange when the pump heads are set at equal flow rates. As perfusate enters the tip of the microperfusion catheter, analytes are exchanged based on a gradient between the interstitial fluid and the perfusate. The sample is then recovered via the "pull" portion of the peristaltatic microperfusion pump, enabling constant sampling volumes and preventing loss of the perfusate into the tissue.
The duration is 60-80 minutes (dependent on the speed of progress resecting portions of the tumor without catheters)
Other names: Joanneum Research cerebral open flow microperfusion
Time frame: 1 year
Number of patients who develop persistent adverse events deemed related (possibly, probably, definitely) to the insertion or use of microperfusate catheters. Adverse events will be measured by CTCAE 5.0.
Time frame: 1 year
Number of patients for whom at least 1 specimen containing > 10 μL microperfusate is successfully collected from 2 or more locations.
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
A Pilot Feasibility Study for Cerebral Open Flow Microperfusion in Patients Undergoing Planned Neurosurgical Resection of Diseased Parenchyma.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06804655
Astrocytoma, Brain (Nervous System) Cancers
Basel, Basel-Landschaft, Switzerland
View Trial DetailsNCT06368934
Astrocytoma, Glioblastoma
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07464925
Astrocytoma, Glioblastoma
Tampa, Florida, United States
View Trial DetailsNCT06161519
Astrocytoma, Brain Diseases
Bethesda, Maryland, United States
View Trial Details